P

Inventor

MORODER LUIS

DE12 patents
⚠️ This page may combine multiple inventors who share the name “MORODER LUIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WILEX AG

3 patents
US7208521B2Apr 24, 2007

Selective inhibitors of the urokinase plasminogen activator

WILEX AG13 citations83
US7049460B1May 23, 2006

Selective inhibitors of the urokinase plasminogen activator

WILEX AG13 citations83
US7038074B2May 2, 2006

Arginine mimetics as factor Xa inhibitors

WILEX AG13 citations83

MAX PLANCK GESELLSCHAFT

3 patents
US5041533AAug 20, 1991

Hinge peptide, a process for its manufacture, and its use for the manufacture of synthetic immunogens

MAX PLANCK GESELLSCHAFT16 citations71
US4677060AJun 30, 1987

Process for determining the pH value in the interior of a cell

MAX PLANCK GESELLSCHAFT6 citations71
US6613769B1Sep 2, 2003

Tryptase inhibitors

MAX PLANCK GESELLSCHAFT2 citations58

VALET GUENTER

2 patents
US4515730AMay 7, 1985

Compounds for determining the pH value in the interior of a cell

VALET GUENTER1 citations57
US4503148AMar 5, 1985

Process for determining the pH value in the interior of a cell

VALET GUENTER3 citations57

WILEX BIOTECHNOLOGY GMBH

1 patent
US6841702B2Jan 11, 2005

Highly selective inhibitors of the urokinase plasminogen activator

WILEX BIOTECHNOLOGY GMBH26 citations87

HUBER ROBERT

1 patent
US8853363B2Oct 7, 2014

Substance binding human IgG Fc receptor IIb (FcγRIIb)

HUBER ROBERT6 citations76

MAX PLANCK GES ZUR FORDRUNGDER

1 patent
US6489327B1Dec 3, 2002

Tryptase inhibitors

MAX PLANCK GES ZUR FORDRUNGDER8 citations64

MAX PLANCK GESSELLSCHAFT ZUR F

1 patent
US7049344B2May 23, 2006

Highly selective inhibitors of the urokinase plasminogen activator

MAX PLANCK GESSELLSCHAFT ZUR F2 citations60